American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Instagram Outage Disrupts Thousands of U.S. Users 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
BETHLEHEM, Pa., May 16, 2017 -- B. Braun Medical Inc., an industry pioneer in offering products not made with PVC and DEHP, will showcase its portfolio of solution containers at the CleanMed 2017 Conference & Exposition on May 16-18 at the Minneapolis Convention Center.
“We’re focused on supplying a marketplace with an increasing demand for safe products,” said Rick Williamson, Vice President of Pharmaceutical and Drug Delivery Marketing at B. Braun. “We’re here for the long haul and making the investments to ensure that the healthcare industry is well served with quality medical supplies so clinicians can provide healing environments for their patients.”
In the past five years, B. Braun has spent more than $500 million in developing innovative ways to offer products not made with PVC and DEHP. B. Braun actively supports policies calling for the industry-wide reduction of these chemicals and natural rubber latex in medical devices to raise awareness and encourage change.
More than four decades ago, B. Braun recognized the environmental and patient risks posed by products containing PVC and DEHP. As a result, B. Braun was the first IV fluids manufacturer to remove these toxic substances from many products, and remains the only supplier that offers a full-line of IV solution containers that are not made with PVC or DEHP.
“B. Braun is committed to finding alternative methods to manufacture safer products, such as our TITAN™ XL irrigation bags and E3® IV containers,” Williamson said.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]
